As a result of the European ban of in-feed growth-promoting antibiotics, new strategies are being developed to increase the resistance to disease in farm animals. In pig production, this is of particular importance during the weaning transition when piglets are subjected to major stressful events, making them highly sensitive to digestive disorders. At this time, the development of both innate and adaptive immunity at the mucosal surface is critical in preventing the potential harmful effects of intestinal pathogenic agents. Strategies aiming at stimulating natural host defences through the use of substances able to modulate immune functions have gained increasing interest in animal research, and different bioactive components a priori sharing those properties have been the subject of in vivo nutritional investigations in pig. Among these, yeast derivates (b-glucans and mannans) are able to interact with immune cells, particularly phagocytic cells. However, studies where they have been fed to pigs have shown inconsistent results, suggesting that their ability to target the sensitive immune cells through the oral route is questionable. The plant extracts, which would benefit from a positive image in the public opinion, have also been tested. However, due to a lack of data on the bioactive components of particular plants and the large diversity of species, it has proved difficult to prepare extracts of equivalent potency and thus, the literature on their influence on pig immunity remains inconclusive. In considering piglet immunity and health benefits, the most promising results to date have been obtained with spray-dried animal plasma, whose positive effects would be provided by specific antibodies and nonspecific competition of some plasma components with bacteria for intestinal receptors. The major positive effect of spray-dried animal plasma is in reducing the infiltration of gut-associated lymphoid tissue by immune cells, which is likely to be the result of a decreased colonisation by potentially harmful bacteria. This review also highlights the limitations of some of the published in vivo studies on the immunomodulatory activity of certain feed additives. Among those, the lack of standardisation of extracts and the heterogeneity of piglet-rearing conditions (e.g. exposure to pathogens) are likely the most limiting.
Introduction
Adding sub-therapeutic doses of antibiotics (AB) to feed has been widely used in the pig industry to enhance production efficiency (Cromwell, 2002) . Concerns about potential risks for human health due to the use and misuse of AB in animal feeds (Dewey et al., 1997) have led to their ban as growthpromoters throughout Europe since 1 January 2006 (Regulation (EC) No. 1831 No. /2003 . Risks to human health include the possibility of AB residues in meat, unapparent carriage of anti-microbial drug-resistant bacteria, and exchange of plasmids from AB-resistant bacteria of swine to human pathogens making them resistant to AB (Dewey et al., 1997; Anadon and Martinez-Larranaga, 1999; Pugh, 2002) . In-feed AB were used not only to improve growth but also to control enteric infections during critical periods such as weaning. Initial experience of an in-feed AB ban in Sweden and Denmark indicated that there was a reduced performance and increased morbidity in nursery pigs, which emphasised the therapeutic use of AB in farms (Stein, 2002) . This underlines the need to develop alternative strategies.
In pigs, the post-weaning period is characterised by an immediate, but transient, drop in feed intake, resulting in alterations in gut architecture and function, making piglets highly sensitive to digestive diseases (Pluske et al., 1997; Lallès et al., 2004) . To help piglets to cope with this transition, -E-mail: Isabelle.Oswald@toulouse.inra.fr various nutritional approaches have been proposed (Lallè s et al., 2007) , including supplementing the diet with substances that increase appetence or have anti-microbial and/ or immunostimulating properties. Amongst the alternatives to in-feed AB, strategies aiming at boosting natural host defences (e.g. immunomodulators), as opposed to those that act directly on the microflora, are attracting a greater level of attention. Indeed, the correct functional development of the gastro-intestinal tract is of crucial importance in controlling potential pathogens during the neonatal and post-weaning period. The development of both innate and adaptive immunity at the mucosal intestinal surface is critical in determining the outcome of the large exposure to new antigens at these times. Paradoxically, the gut is required to be sufficiently permeable to allow the absorption of nutrients, whilst at the same time it must prevent the harmful effects associated with the replication and absorption of potential pathogens (or their products). If for the adult the main aim is the maintenance of gut homoeostasis, for the young animal it is to establish a favourable steady state. Weaning affects the ontogeny of immune functions, largely as a consequence of the withdrawal of milk, which has important implications for passively modulating immune responses through both suppressive and enhancing pathways. The aim of immunomodulating substances is to help piglets develop 'appropriate' active responses from both innate and acquired immunity.
Immunomodulating substances used as in-feed additives have to fulfil a variety of properties. From a technical point of view, they have to be resistant to the processes used in feed manufacturing. From a regulatory viewpoint, they have to be safe for farm animals and must not affect food safety. Those products should also share a positive image towards the public, who are increasingly sensitive to ethical considerations and whose opinion influences legislation (Florkowski et al., 1998) . Thus, products from natural sources will probably be easily accepted by the public. Finally, these alternatives must be effective in their purpose, namely to act as growth-promoters and provide health benefits to piglets, which will be the main focus of the present review.
Following a brief description of the development of the piglet mucosal immune system, this paper will focus on groups of in-feed alternatives that have been suggested to show immunomodulatory properties and that have been the purpose of in vivo investigations in pigs. These include yeast derivates, plant extracts and animal by-products.
Piglet immunity: implications for the oral application of immunomodulators
The immune response to oral delivery of antigens is orchestrated by a well-developed local intestinal mucosal immune system ( Figure 1 ). On the one hand it must respond with vigour to potential pathogens, whilst on the other inappropriate responses to dietary antigens and commensal bacteria may lead to harmful allergic or damaging inflammatory conditions. In adult animals, these potentially harmful responses are downregulated by a process known as oral tolerance, but at birth the piglet's mucosal immune system is poorly developed and it has been hypothesised that this may lead to inappropriate responses to food and microbial antigens in the post-weaning period. The kinetics of development of the gut immune system, which will be described in the following (summarised in Table 1) , may therefore play a critical role in determining the outcome of the response to feed antigens.
The development of the gut mucosal immune system Organised lymphoid tissues. The porcine small intestinal wall contains Peyer's patches (PP) in the jejunum and ileum ( Figure 1 ). Whereas jejunal PP are several centimetres in length and located at the anti-mesenteric site of the gut, the ileal PP is a continuous band of up to 2 m in length (Rothkö tter and Pabst, 1989) . The postnatal development of these two types of PP is different. For a short period of time, the ileal PP resembles the characteristics of the ileal PP in lambs with tall, elongated follicles and a small dome area (Barman et al., 1997) . Jejunal PPs have rounded follicles and a larger dome area. Microfold cells (M cells) are present in the follicle-associated epithelium of both types of PP (Gebert et al., 1994) , and play a specialised role in sampling antigen from the gut lumen. Their microfolded apical cell membrane enables endocytotic antigen uptake, and with lymphocytes located in pockets of their basolateral cell membrane, a close interaction of antigens and lymphocytes is possible (Gebert et al., 1996) . Similarly, cellular processes of dendritic cells (DC) are also in close to the basolateral membrane of M cells (Bimczok et al., 2006) . Following (Bienenstock et al., 1983) . The rapid migration of IgA 1 immunoblasts from intestinal lymph into the intestinal mucosa has also been demonstrated in lymph duct cannulation experiments in pigs (Rothkö tter et al., 1999b) .
Lamina propria lymphocytes. The lamina propria of adult pig is well supplied with leucocytes ( Figure 1) , and in contrast to many other species the immunological organisation of the lamina propria in the pig intestine shows a high level of organisation (Bailey et al., 1996; Haverson et al., 1999) . Within the villous lamina propria the tissue deep to the capillary plexus contains predominately CD4
1 T-cells whilst CD8
1 cells occur luminally and in the epithelium. Antigen-presenting cells are present in large numbers in the lamina propria of many species including the pig (Haverson et al., 2000) . The lamina propria around the intestinal crypts contains cells staining for Igs (predominantly IgA, presumably plasma cells), with few T-cells or DC, but with myeloid cells with the characteristics of macrophages and granulocytes (Rothkö tter et al., 1991) .
At birth, only small numbers of leucocytes are found in the lamina propria and in pigs it becomes populated according to a clearly staged time course. DC that are strongly major histocompatibility complex class II (MHC II 1 ) and co-express CD45 and CD16 appear within the first week (Haverson et al., 2000) . In contrast, T-cells appear more slowly and undergo a phased pattern of appearance. An unusual cell type, characterised by the expression of CD2, but lacking CD4 and CD8, has been shown to co-express CD3 and can therefore be classified as CD4
2

CD8
2 T-cells (Rothkö tter et al., 1991; Haverson et al., 1999) . Together with a second T-cell population, characterised as CD2
CD8a/a 1 , they form the dominant T-cells migrating into the jejunal tissue during the first week to 10 days of life. Interestingly, while conventional CD4
1 and CD8a/b 1 T-cells in this site in adult animals express low levels of CD45RC, consistent with advanced memory status, a significant proportion of these unusual CD2
CD8a/a 1 T-cells express moderate to high levels of CD45RC, suggesting that they may be less antigen-experienced (Bailey et al., 1998; Haverson et al., 1999) . During the second and third weeks of life, increasing numbers of CD4
1 T-cells appear and CD8 1 cytotoxic T-cells only appear in significant numbers after the third week of life (Rothkö tter et al., 1991; Haverson et al., 1999) . Similarly, IgA 1 plasma cells have been reported to appear in significant numbers as late as 3 to 6 weeks of life. The final architecture containing large numbers of DC and CD4
1 T-cells of resting, advanced memory phenotype, transcribing interleukin-4 (IL-4) but being unable to secrete IL-2 and responding to further activation by apoptosis is not achieved until the pig is approximately 6 weeks old (Bailey et al., 2005) .
Intraepithelial lymphocytes. The intraepithelial lymphocytes (IEL) are a large population of cells with up to 2 3 10 7 cells present per gram of porcine jejunal mucosa (Figure 1 ). They are mostly CD8
1 T-cells with a significant proportion expressing the CD8aa homo-dimer (Rothkö tter et al., 1999a) . In the postnatal period, the frequency of IEL increases with age and this can be influenced by the luminal contents. For example, their number is markedly reduced with total parenteral nutrition (Kansagra et al., 2003) .
The induction of immune responses in the postnatal period In order to generate an immune response, the ingested antigens must pass the epithelial barrier by either transcellular (vesicular transport) or paracellular routes. The uptake of antigens occur via either fluid-phase or receptor-mediated transport, followed by intracellular processing or simply exocytosis. Enterocytes are non-phagocytic cells that, in health, prevent the passage of macromolecules through the epithelium (Shah and Walker, 2002; Oswald, 2006) . Additionally, access to the enterocyte surface is restricted by local secretions like IgA and mucins, closely packed villi, and a thick glycocalyx. However, the epithelial barrier cannot completely prevent antigen uptake (Macdonald and Monteleone, 2005) . Although the paracellular antigen entry by diffusion from the lumen is avoided by tight junctions at the apical poles, antigens can cross through breaks in tight junctions (Neutra et al., 2001) . Additionally, the tightness of tight junctions can be affected by host mediators and soluble environmental factors (Bouhet et al., 2004) . For example, in cases of immaturity and diseases like viral gastroenteritis, bacterial infection and inflammatory bowel disease, the well-integrated function of the intestinal epithelium is affected, and antigens of every kind can enter. In health, only penetrating pathogens (Niedergang and Kweon, 2005) or invading bacteria (Cossart and Sansonetti, 2004) find a way into the epithelial cell.
DC are located throughout the intestinal immune system and as sentinel cells they perform important immunosurveillance functions (Stockwin et al., 2000) . They are found in the villous lamina propria, in the sub-epithelial dome and the interfollicular regions of the PP (Figure 1 ), as well as in the mesenteric lymph nodes (MLN). Although it is feasible that DC residing in the MLN take up free antigens or pathogens derived from afferent lymph, antigen uptake is primarily performed by the immature peripheral DC located in the villous lamina propria and the sub-epithelial dome of PP. Interestingly, even non-replicating particulate antigens can generate specific immune responses, although they cannot normally cross the intestinal barrier. One important mechanism responsible for this may be antigen uptake by lamina propria DC that extend cytoplasmic processes into the gut lumen between the enterocytes (Niess and Reinecker, 2005) . These cytoplasmic processes also exist in the pig, but they are relatively rare (Bimczok et al., 2006) . After antigen uptake, the cells alter their chemokine receptor pattern, which allows them to migrate to T-cell regions of organised lymphoid tissue (i.e. interfollicular regions of the PP or MLN), where antigen presentation takes place (Fleeton et al., 2004) . Cannulation studies of pseudoafferent intestinal lymph in rats and in pigs have shown that DC are constantly migrating from the gut wall to the MLN, even in the absence of overt antigenic stimulation (Macpherson and Uhr, 2004) . This would suggest that these cells play an important role in the maintenance of tolerance. Indeed, a significant population of these cells contained particles of apoptotic cells (Huang et al., 2000) . Phenotypic analyses of migrating DC in porcine pseudo-afferent intestinal lymph suggest that migration routes are mainly from the villous lamina propria to MLN, and from the sub-epithelial domes to the interfollicular regions of the PP (Bimczok et al., 2005) .
The postnatal period is critical in terms of the development of an effective mucosal immune system that is capable of the adaptation to commensal bacteria, tolerance towards nutritional components and defence against pathogens in the gut lumen 2007; Stokes et al., 2004; Rothkö tter et al., 2005) . Weaning is a period during which there is considerable change in the magnitude and diversity of exposure to environmental antigens derived from food and potentially pathogenic organisms. Under 'natural conditions' weaning is a gradual process, and in piglets it is not complete until 10 to 12 weeks of age. This is however not normal husbandry practice and piglets are more commonly weaned abruptly at 3 to 5 weeks. As a consequence, neonatal pigs experience a transient immune hypersensitivity to dietary antigens when weaned at 3 weeks of age, often associated with clinical symptoms, e.g. diarrhoea, weight loss and enteritis (Bailey et al., 1993; Stokes et al., 2004) . In contrast, if piglets are allowed to suckle their dams, until they voluntarily wean themselves at approximately 12 weeks, they develop oral tolerance to the dietary antigens without clinical symptoms (Bailey et al., 1994) . The initial and characteristic lesions of post-weaning diarrhoea are a crypt hyperplasia and a severe villous atrophy in the small intestine, which is associated with a fall in brush border enzymes (disaccharidases, sucrase and lactase) and malabsorption. These changes occur within 3 to 4 days of weaning and a partial recovery occurs after 7 to 10 days. They are partly related to a transient hypersensitivity reaction to antigens in the post-weaning diet as comparable effects are observed in the complete absence of bacteria. However, the weaning effects are most commonly associated with an increase in the proliferation of gut bacteria and the hypersecretory effects of bacterial enterotoxins (Sahin et al., 1991) .
Natural alternatives to in-feed antibiotics
In the following, the capacity of selected plant extracts and other natural substances to improve the immune status of the pig is reviewed. For each type or class of substances, effort has been made to synthesise in tables major elements concerning experimental designs, and immune parameters which have been studied by differentiating the local intestinal immune response and the systemic immunity. Indeed, in most of the experiments, the peripheral blood immune cells are more easily studied than mucosal immune cells. However, only two percent of all lymphocytes are in the peripheral blood (Blum and Pabst, 2007) and their half life in the blood is about 30 min. Thus, the observed reactions reflect the responses of cells that may have their origin in the PP, in the MLN or in the tonsils -all compartments of the mucosal immune system. Alternatively, the peripheral blood lymphocytes may be spleen-derived or come from peripheral lymph nodes. Thus, immune reactions after an in-feed application of natural immunomodulators cannot directly be linked to a defined site of origin. So far, it is often difficult to explain whether their reaction pattern depends on mucosal or systemic immune responses.
In-feed modulators of piglet immunity Yeast derivates Interest in the impact of polysaccharides on immunity has increased rapidly over the past decade and this is reflected in the large number of reviews dealing with this topic (Bohn and BeMiller, 1995; Williams, 1997; Tzianabos, 2000; Brown and Gordon, 2003) . A variety of polysaccharides from different natural sources have the ability to modulate the immune system. Among those, b-D-glucans and the carbohydrate portion of mannoproteins, the a-D-mannans, have been recognised to be responsible for modulating the immune responses in mammals through specific interactions with different immunocompetent cells (Kogan and Kocher, 2007) . A direct interaction of b-D-glucans with macrophages and polymorphonuclear cells confers to these products their immunomodulatory properties (Tzianabos, 2000; Brown and Gordon, 2003) . Mannans alter the immune response by specific links with mannose receptors, present on many cells of the immune system (Lee, 1988) , such as macrophages (Tzianabos, 2000) .
Glucans and mannans are already proposed as potential immunomodulatory agents for prophylaxis and therapy of infections in human (Masihi, 2000) and in farm animals including pigs Kogan and Kocher, 2007) . Numerous commercial preparations derived from yeast cell walls, particularly rich in glucans and mannans, are available as in-feed supplements for pigs (Table 3) . However, the composition and the purity of these products often remain unknown. This could partly explain the high variation of incorporation levels (from a factor 1 to 500 for glucans, and a factor 1 to 30 for mannans) of these commercial preparations in feed (Table 2) . Moreover, the literature dealing with diet incorporation of yeast cell wall extracts often refers to only one of those two compounds, but yeast derivates usually contain both polysaccharides.
Glucans. b-glucans extracted from the cell wall of Saccharomyces cerevisiae is the most common source used for animal in-feed complements. It is a b-1,3-glucan with long b-1,6-glucan branches, whose structure is different from the b-glucans extracted from bacteria (linear b-1,3-glucan), cereals (b-1,3/1,4-glucan) and fungi (short b-1,6-glucan branched b-1,3-glucan). Their different chemical structures would be expected to be reflected in their different bioactivities (Bohn and BeMiller, 1995) . Furthermore, depending on the extraction procedure, soluble and insoluble fractions that have different activities can be present together or separately (Tzianabos, 2000) . Thus, the form under which glucans are included in diet will probably influence their biological properties.
Literature dealing with effects of glucans on local intestinal immune response in pigs is very scarce (Table 2) . In finishing pigs, the ileal contents of IgM, IgA, or CD4 1 and CD8
1 T-cells were not modified by glucans supplementation (Sauerwein et al., 2007) . A higher incorporation dose of b-glucans (2.5%) led to increased intestinal tumour necrosis factor-a (TNF) and IL-1b mRNA but also in intestinal IL1-receptor antagonist (IL-1Ra) mRNA in pigs challenged 4 h earlier with lipopolysaccharide (LPS) (Eicher et al., 2006) . These changes were not associated with alterations in blood TNF-a within hours following the inflammatory challenge. Biological significance of these results is difficult to assess as those cytokines are implicated in both pro-inflammatory (TNF-a and IL-1b) and antiinflammatory (IL-1Ra) processes.
Much interest has been paid to the effects of glucans on systemic immune responses, particularly innate immunity. b-glucans have been shown to have anti-inflammatory properties. In vitro, IL-6 and TNF-a production by lymphocytes isolated from peripheral blood of weaned piglets supplemented with b-glucan and stimulated with LPS was decreased, whereas IL-10 production was enhanced . Those cytokine patterns were confirmed in vivo in piglets fed diets supplemented with glucans, and challenged intraperitoneally with LPS 2006) . Taken together, these in vitro and in vivo analyses show that dietary b-glucans prevent the elevation in pro-inflammatory cytokines whilst enhancing the production of anti-inflammatory cytokines in response to an inflammatory challenge. Consistently, glucans have been shown to modulate the acute phase response, whose regulation is known to be orchestrated by pro-inflammatory cytokines like IL-1, IL-6 or TNF (Baumann and Gauldie, 1994; Niewold, 2007) . In piglets, blood haptoglobin concentrations increase during the 2 weeks following an early weaning (18 days), then remain stable (Dritz et al., 1995) . A supplementation with 0.025% or 0.05% of b-glucans partly suppresses this increase (Dritz et al., 1995) . These results were not confirmed in piglets weaned at 28 days (Hiss and Sauerwein, 2003; Sauerwein et al., 2007) . However, it should be noted that in these later experiments, haptoglobin concentration increased only during 1 week post-weaning, which could have limited the impact of glucans on this response.
As a known target for glucans, the function of neutrophils and macrophages has been widely investigated (Brown and Gordon, 2003) . Dietary b-glucans had no consistent effects on the ability of peripheral blood neutrophils to generate reactive oxygen intermediates, neutrophil-mediated antibodydependent cellular cytotoxicity and on neutrophil phagocytic activity (Dritz et al., 1995; Sauerwein et al., 2007) . Similarly, lung macrophage production of superoxide anion and bactericidal activity, as well as the expression of CD14, were not influenced by the inclusion of b-glucans in the diet (Dritz et al., 1995) . Thus, the predicted modulation of neutrophil and macrophage functions by glucans was not confirmed in in vivo experiments, which may partly be explained by the limiting ability of glucans to be delivered to those cells after an oral supplementation. Whereas the ability of lymphocytes to proliferate is also insensitive to a feed supplementation with glucans (Hiss and Sauerwein, 2003) , the production of the different classes of Igs is influenced in a dose-dependent manner with lower and higher doses favouring IgA and IgG responses, respectively (Sauerwein et al., 2007) . This could be partly correlated to the different pattern of lymphocyte subclasses (helper and cytotoxic T-cells) observed in response to a supplementation with b-glucans (Hahn et al., 2006) . In-feed modulators of piglet immunity However, those variations are inconstantly reported, and appear to be related to the period of supplementation Hahn et al., 2006) . The effect of dietary supplementation with b-glucans on the response to systemic immunisation has produced contrasting results. For example, whereas b-glucan-supplemented piglets vaccinated with atrophic rhinitis vaccine produced a transiently lower antibody response (Hahn et al., 2006) , pigs injected with ovalbumin and receiving b-glucans at a dose of 0.005% mounted a transiently higher antibody response . b-glucans did not enhance the efficiency of a vaccination with porcine reproductive and respiratory syndrome (PRRS) virus (Hiss and Sauerwein, 2003) , or different EnteroToxinogenic Escherichia coli (ETEC) antigens (Decuypere et al., 1998) .
The effect of b-glucans on the passive transfer of immunity has also been studied by immunisation of sows with strains of E. coli implicated in neonatal diarrhoea (Decuypere et al., 1998) . Whereas the titre of antibodies specific to K88ab and K99 was not enhanced in colostrum of glucan-fed sows, it was elevated in their milk as compared to control sows. The authors noted that the health score (mainly due to neonatal diarrhoea) of piglets whose mother was submitted to a b-glucan regimen was severely impaired during 14 days post partum, but that the aetiological agent was not one of the ETEC strains against which sows were immunised.
In conclusion, the effects of glucans on immunity are not predictable and their ability to act as growth-promoters is also not reliable (Table 2) . It should be highlighted that many of the studies have been performed in 'clean' environments, where morbidity rates are low, and that beneficial effects on health are much more difficult to detect in such environments.
Mannans. The potential protective activities of mannans may include their ability to 'adsorb' enteric pathogens and to modulate immune functions . To our knowledge, only two publications have investigated the effects of dietary mannan supplementation on local intestinal immune response in swine (Table 3) . Even if mannans do not have any effect on the number of macrophages in intestinal lamina propria, their function seems to be enhanced. Indeed, the phagocytosis of sheep red blood cells by macrophages isolated from jejunal lamina propria was increased by inclusion of 0.3% mannans in the basal diet (Davis et al., 2004a) . The recruitment of lymphocytes into the small intestinal lamina propria is reduced in piglets fed mannans (Lizardo et al., 2008) and their profile is also influenced. Indeed, the ratio of CD3
1 CD4 1 /CD3 1 CD8 1 T-cells was lowered 21 days post-weaning, indicating a greater proportion of CD8
1 T-cells in mannan-supplemented pigs (Davis et al., 2004a) . After birth, infiltration of lamina propria with CD8
1 T-cells is usually delayed (4 weeks after birth) as compared to infiltration with CD4 1 cells, which can begin as early as 2 weeks of age (Bailey et al., 2001 ). This observation could be an indication that mannan supplementation would enhance the establishment of a mature Gallois, Rothkö tter, Bailey, Stokes and Oswald T-cell repertoire within the gastro-intestinal tract. However, further work is still needed to confirm this hypothesis. Systemic immune response to dietary mannans has been studied in more detail. For example under normal breeding conditions, serum a-1-acid glycoprotein concentration was not altered by inclusion of dietary mannans (Davis et al., 2004a) , whereas piglets fed with 0.3% of phosphorylated mannans exhibited a decreased blood neutrophils : lymphocytes ratio, suggesting that mannan supplementation could alleviate the inflammatory response associated with the stress of weaning (Davis et al., 2004a) . The increased blood lymphocyte population among leucocytes in mannan-fed animals could be linked more to B than to T-cells. Indeed, 3% of brewer's yeast (which corresponds to a final level of 0.16% of mannan oligosaccharide) only tended to increase the piglet serum level of IgG when used alone, but substantially increased this level when fed with the acidifier, citric acid (White et al., 2002) . Conversely, blood proportions of CD4 1 or CD8 1 lymphocytes are insensitive to mannan supplementation . The proliferative response of peripheral blood lymphocytes was generally found not to be affected by the inclusion of mannans in the diet of nursery piglets (Davis et al., 2002 (Davis et al., , 2004a (Davis et al., and 2004b , but when continuously incorporated at a dose rate of 0.3% the ability of lymphocytes to proliferate after a stimulation with a pokeweed mitogen (non-specific proliferation of B-and T-cells) or with phytohemaglutinin (proliferation of primarily T-cells) was reduced (Davis et al., 2004b) . The authors suggested that this altered immune function may explain the beneficial effects of mannans for piglet growth. However, there are no data concerning morbidity or mortality to assess the health effects of such an immune depression.
In piglets challenged with Salmonella enterica serotype Typhimurium, serum haptoglobin concentrations were increased in 0.15% mannan-fed piglets 6 and 13 days postinfection as compared to piglets fed the basal diet either alone or enriched with AB (Burkey et al., 2004) . Serum IL-6 was not altered by mannan supplementation, but this could be explained by the absence of a response on this cytokine following challenge with this pathogen (Burkey et al., 2004) . Contrary to carbadox, mannans failed to reduce the length of the period of hyperthermia observed after infection with S. enterica and did not promote growth (Burkey et al., 2004) . Total levels of serum IgA, IgM and IgG were not modified by dietary mannan, in piglets challenged or not with an enterotoxigenic strain of E. coli K88 (White et al., 2002) .
As for glucans, the influence of mannans on immunity is not always reliable, as well as their effects on piglet performances. In piglets challenged with enteric pathogens (E. coli K88, S. enterica), health benefits of dietary mannans are not consistent.
Plant extracts
Empirical evidence suggests that plant extracts may offer benefits in boosting the immune system; thus, preventing disease in production animals (Wenk, 2003) and plantderived products have gained increasing interest as possible feed additives for non-ruminant species (Windisch et al., 2008) . Plants, and where they have been identified their bioactive components, are very diverse and their potential to enhance pig health and immunity has only been scarcely evaluated in vivo (see Table 4 ). Moreover, most studies have used a mixture of compounds, which does not allow the investigation of the immune properties of a specific bioactive component.
Herbaceous plants. Herbs and spice extracts have been used extensively in different parts of the World to treat a variety of human diseases (Stein and Kil, 2006) . Gastrointestinal disorders have been treated with a number of different plant extracts including garlic, peppermint, chamomile or aloe (Amagase et al., 2001; Akerreta et al., 2007; Rodriguez-Fragoso et al., 2008) . Some herbs like Echinacea, liquorice, cat's claw and garlic are claimed as immunoenhancers (Craig, 1999) . The essential oil of the plant is often the biologically active component, but other extracts can also display biological activities.
The Labiatae constitutes a large family of herbs: basil, dill, fennel, marjoram, mint, rosemary, oregano, sage and thyme (Craig, 1999) . Mixtures of essential oils based on thymol and carvacrol whose major sources are thyme and oregano, respectively (Burt, 2004) , seem promising due to their antimicrobial (Kim et al., 1995; Cosentino et al., 1999; Baydar et al., 2004) and potential immunomodulatory properties (Woollard et al., 2007) . A plant extract containing 6% of carvacrol and 0.14% of thymol, incorporated at 0.05% to 0.15% in a pig diet, had no effect on the plasma levels of the acute phase proteins, haptoglobin and C-reactive protein (Muhl and Liebert, 2007) and the inclusion of a commercial plant product composed of oregano oil mixed with anis and citrus oils did not improve the health status of piglets (Kommera et al., 2006) . In contrast, an extract of Origanum vulgare, enriched with both thymol and carvacrol in similar proportions, was reported to protect low-weight growingfinishing pigs from disease (Walter and Bilkei, 2004) . This health benefit was associated with an increased proportion of CD4
1
, CD8
1 and double-positive T-cells in peripheral blood and MLN (Walter and Bilkei, 2004) . Thymol used alone enhances total IgA and IgM serum levels and exhibits some local anti-inflammatory properties, as indicated by a reduction in TNF-a mRNA in the stomach (Trevisi et al., 2007) . In vitro, cinnamaldehyde, the main component of cinnamon essence, also has anti-microbial (Burt, 2004) and immunomodulatory (Koh et al., 1998) properties. A plant extract containing 5% of carvacrol (Origanum spp.), 3% of cinnamaldehyde (Cinnamonum spp.) and 2% of capsicum oleoresin (Capsicum annum), included in the feed at a 0.03% level, led to a decreased number of jejunal IEL, and an increased number of lymphocytes in the colonic lamina propria . Conversely, mononuclear cell subsets from ileal PP were not affected by this plant extract combination and only the percentage of B lymphocytes was reduced in lymph nodes of piglets . Chinese pharmacopoeia describes the use of numerous herbal formulations to cure a wide variety of diseases. Among those, Bahzen is a medicine composed of eight different herbs (Atractylodes ovata, Codonopsis pilosula, Poria cocos, Glycyrrihiza uralensis, Angelica sinensis, Ligusticum chuanxiong, Paeonia albiflora and Rehmannia glutinosa) whose effects have been tested in vivo in pigs (Lien et al., 2007) . Bahzen increased white blood cell counts, without leukocytosis, and enhanced IL-6 and TNF-a in the serum of pigs challenged with LPS, compared to negative and positive (AB) control animals (Lien et al., 2007) . Serum IgG levels and blood neutrophil activity in Bahzen and AB groups were increased. However, Bahzen did not modulate acquired immunity, as measured by specific antibody responses directed towards different antigens (sheep red blood cells, ovalbumin) (Lien et al., 2007) . Piglets fed with Bahzen also grew faster than control piglets (Lien et al., 2007) . The authors speculated that Bahzen-fed piglets had an increased ability to respond to an inflammatory stress, and that this may be beneficial for piglet health. Equally, it is possible to argue that an increased inflammatory response could be detrimental to piglet health.
In-feed modulators of piglet immunity
An abundance of plants of the Echinacea family in pasture is used as an indicator of 'good health'. The main bioactive components of Echinacea purpurea are chicory acid and alkamids. When included as juice or cobs in the post-weaning diet or that of finishing pigs, growth performances are not improved, but feed efficiency tends to be increased (Maass et al., 2005) . Blood parameters, including cell count and lymphocyte proliferation, were not modified by dietary treatment but the health status of piglets was good throughout the trial. Moreover, the response to immunisation of piglets with a vaccine against Erysipelothrix rhusiopathiae was enhanced by the inclusion of E. purpurea into the diet of finishing pigs (Maass et al., 2005) . This could be an indication for the health-promoting properties of Echinacea, but further studies would be required to confirm this.
Whilst the bulk of b-glucans used in feed industry is derived from yeast cell wall (see previous section), b-glucans from the Chinese herb Astragalus membranaceus have also been tested (Mao et al., 2005; Yuan et al., 2006) . Dietary A. membranaceus increased the white blood cell count, mainly through the contribution of CD4 1 lymphocytes (Yuan et al., 2006) . The proliferation of T-cells isolated from peripheral blood in weanling pigs was also increased in a dose-dependent manner in b-glucans-fed piglets (Mao et al., 2005) . Concomitantly, b-glucans from Astragalus increased blood concentration in IL-2 (Mao et al., 2005; Yuan et al., 2006) and interferon-g (IFN-g) (Yuan et al., 2006) , but IL-4 and IL-10 concentrations remained unchanged (Yuan et al., 2006) . This cytokine profile suggests a Th1 bias, which is in accordance with the enhancement of cellular immunity conferred by glucans. Plant b-glucans do not influence humoral immunity, as their inclusion in diet did not alter specific antibody titres following immunisation with ovalbumin (Yuan et al., 2006 ). A 0.05% level of glucans extracted from A. membranaceus counteracted the increased plasma concentrations of In-feed modulators of piglet immunity IL-1b and prostaglandin E2 induced by an LPS challenge. Surprisingly, this effect was less pronounced when included at a dose of 0.1% in the diet (Mao et al., 2005) . Thus, b-glucans from A. membranaceus exhibited anti-inflammatory properties (decrease in IL-1b synthesis) and promoted T-lymphocyte proliferation (which may be partly linked to the enhanced serum IL-2), but had no positive effects on humoral immunity. These immune modulations may be beneficial for the piglets to fight against infections, but the health status of piglets was not stated in these studies. Sugar cane extracts display a wide range of biological effects, including immunostimulating and growth-promoting properties as shown in chicken (El-Abasy et al., 2002) . In pigs, sugar cane extract prepared by chromatographic separation on an ion exchange column could enhance innate immunity, through increased NK (natural killer) cell cytotoxicity and phagocytic function of monocytes and neutrophils (Lo et al., 2005) . As morbidity and mortality rates remained very low in this experiment, it is not possible to speculate whether those immune modulations induced by sugar cane extract would improve the resistance of piglets to infection. Moreover, the potential bioactive component(s) from this particular extract of sugar cane have not been identified.
Genistein and daidzein, two isoflavones found in soybean products, have also been suggested to act as immunomodulators when given orally. After oronasal inoculation of piglets with PRRS virus, dietary daidzein failed to decrease serum titres of virus (Greiner et al., 2001b) , whereas genistein minimised the viremia from day 4 to day 24 post-inoculation, as well as the serum concentration of IFN-g (Greiner et al., 2001a) . Serum a-1-acid glycoprotein concentration was not modulated by daidzein (Greiner et al., 2001b) , but was increased during periods of high viremia by genistein (Greiner et al., 2001a) . This enhanced a-1-acid glycoprotein response in genistein-fed piglets supports the hypothesis of a greater and more effective immune response, which could explain the lower viremia (Greiner et al., 2001a) . Accordingly, lower serum IFN-g concentration in genistein-fed animals is in agreement with the greater virus elimination and a quicker return of IFN-g to basal levels (Greiner et al., 2001a) . Despite the different effects on viremia, both isoflavones were efficient in promoting growth in piglets challenged with PRRS virus, which suggests that their mechanisms of action would differ. It would be of interest in future to test their ability to enhance immune responses and health during a challenge with an intestinal pathogen.
Ligneous plants. An extract of the South American tree Quillaja saponaria is widely used as a vaccine adjuvant (Kensil et al., 2004) , and whose active ingredient appears to be the saponin fraction (Milgate and Roberts, 1995) . As saponins are known to enhance immunity via the intestinal route, their use in animal nutrition has been the subject of investigation (Francis et al., 2002) . Dietary treatment with crude soap bark of Q. saponaria, ranging from 125 to 500 mg/kg, did not counteract the negative effects on feed intake and growth induced transiently by a challenge with Salmonella enterica serovar Typhimurium (Turner et al., 2002b) . Q. saponaria also failed to modulate the rise in serum haptoglobin, a-1-acid glycoprotein and IgM concentrations induced by this challenge 7 and 14 days postinfection (Turner et al., 2002b) . The phagocytic function of peripheral white blood cells tended to be depressed in challenged pigs fed with high doses of Q. saponaria, but not with low doses (Turner et al., 2002b) . It has been suggested that these 'weak immune modulations' may be due to the low purity of the extract used (Ilsley et al., 2005) , which could reach a maximal level of 10% of saponins. Moreover, tannins, which could be as high as 15% in a crude extract of Q. saponaria, might have induced a detrimental response, as they are known to have anti-nutritional properties (Singh et al., 2003) . Thus, Ilsley et al. (2005) incorporated a saponin extract from Q. saponaria in the diet, alone or in combination with curcumin, which has been shown to modulate lymphocyte-mediated immune functions in mice (Churchill et al., 2000) . The combination of both products did not result in adverse or synergistic effects (Ilsley et al., 2005) . Whereas piglet immune responses were not influenced by curcumin, the feed intake and serum IgA, IgG and C-reactive protein concentrations were transiently increased in saponin-fed piglets. The subsequent negative impact of saponin on feed utilisation, assessed by a decreased feed : weight gain ratio, could result from increased dietary requirements to mount an immune response (Ilsley et al., 2005) . However, as the health status of piglets remained very good throughout the experiment, it is difficult to predict whether such a response may have been beneficial or detrimental to piglets during the time of an infection.
Seaweed extracts. Seaweed extracts are also known to have immunomodulatory properties (Yoshizawa et al., 1993) . To date, we are only aware of one study that presents data on influence of a seaweed extract on the immune parameters in pig production. This extract was derived from Ascophyllum nodosum, and different levels of incorporation ranging from 0% to 2% were tested in piglets orally challenged with 6 3 10 9 CFU (colony forming units) of Salmonella enterica serovar Typhimurium (Turner et al., 2002a) . Increasing levels of A. nodosum tended to linearly enhance the feed intake, but decreased the feed efficiency during the 4 weeks following the weaning of piglets. The challenge with Salmonella had only moderate effects on piglets, and dietary A. nodosum had no influence on immune responses irrespective of whether the piglets were infected or not. In vitro, a dose of 10 mg/ml of A. nodosum (greatly exceeding the highest level of feed incorporation level of 2%) was able to activate porcine alveolar macrophages to secrete prostaglandin E2. However, this dose did not alter the secretion of IL-10 by splenocytes (Turner et al., 2002a) . Taken together, the in vitro and in vivo data suggest that A. nodosum extract probably has only little direct effect on gut immune system in pig.
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Animal by-products Spray-dried animal plasma. The biological properties of spray-dried plasma (SDP), a by-product of commercial slaughtering facilities, have been investigated in pig nutrition (Coffey and Cromwell, 2001 ). Spray-dried animal plasmas are characterised by a rich protein content, whose digestibility and amino acid composition are similar to those of the proteins in sow's milk (van Dijk et al., 2001) , and whose Igs content can represent 24% to 25% (Niewold et al., 2007) . Plasma from both bovine and porcine origins seem efficient in improving performances of piglets, and the IgG fraction would appear to be the main component responsible for the growth-promoting properties for these products (Pierce et al., 2005) . The Igs may prevent viruses and bacteria from interacting with the gut wall, resulting in an improvement of gut function (Coffey and Cromwell, 2001) . One major problem is the stability of Igs during the manufacturing process of SDP. The most critical step would be spray-drying, which can lead to a 30% loss of Igs activity . Further processing to pellets would not lead to appreciable losses. It is important to remember that the use of non-sterilised products of animal origin as feed ingredients for animals poses a potential health risk, through the spread of certain infectious diseases. Despite spray-drying being shown to eliminate viable pseudorabies and PRRS viruses (Polo et al., 2005) , the use of SDP originating from slaughter animals that have been subjected to veterinary inspection is required. Indeed, it should be kept in mind that the use of non-sterilised products of animal origin as feed ingredients for animals remains a health risk practice, which is strictly regulated in Europe (Regulation (EC) No. 1774/2002 currently under revision). Moreover, as recently illustrated by the use of animal flour in animal feed and the bovine spongiform encephalopathy crisis, the public opinion is concerned by the inclusion of animal by-products in livestock feed. The meat consumers' confidence could, in the future, represent a limiting factor to the use of SDP and other animal by-products in animal nutrition.
The effects of SDP on local intestinal immune responses have been widely studied in pigs (Table 5) . Results are concordant and reveal that SDP prevents the infiltration of gut-associated lymphoid tissue by immune cells, including macrophages and lymphocytes (Jiang et al., 2000; Nofrarias et al., 2006 and 2007) . This decreased infiltration is likely to be a reflection of a lower antigenic challenge (Nofrarias et al., 2007) . Additionally, the jejunal expression of the proinflammatory cytokines IL-8 and TNF-a was decreased in 6% SDP-fed piglets 15 days after a challenge with ETEC K88, irrespective of their status for K88 receptor (Bosi et al., 2004) . This decreased inflammatory response was associated with a lower histopathological score in SDP-fed piglets, thus suggesting that SDP would be efficient in helping piglets fight against infections.
Concerning systemic immune responses, a 6% or 10% supplementation of the diet with porcine plasma did not modulate the increase in blood white blood cell count that normally occurs during the 2 weeks following weaning (Jiang et al., 2000; Nofrarias et al., 2006 and 2007) . SDP did not influence serum IFN-g or TNF-a under basal conditions (Touchette et al., 2002) , but when stimulated with an intraperitoneal LPS injection, SDP-fed piglets showed exacerbated increases in serum levels of IFN-g and TNF-a associated with severe intestinal damage, suggesting that SDP-fed piglets would be more susceptible to certain immunological challenges (Touchette et al., 2002) . Similarly, in piglets challenged intravenously with LPS, the increase in serum IL-6 and IL-1b was exacerbated in SDP-fed piglets, but there was no evidence of an effect on mRNA cytokine levels in the liver, thymus or spleen (Frank et al., 2003) . Conversely, SDP supplementation led to a decrease in Creactive protein concentration but not in haptoglobin (Frank et al., 2003) . In those models, the extremely high dose of LPS (75-150 mg/kg of BW) as well as the route of administration (intraperitoneally or intravenously) preclude from concluding on the plasma effects on inflammatory responses when piglets are exposed to pathogens via the enteral route.
The growth-promoting properties of SDP that are usually reported (Jiang et al., 2000; Bosi et al., 2004; Nofrarias et al., 2006 and 2007; Niewold et al., 2007) are more commonly observed with SDP from porcine than bovine origin (Hansen et al., 1993; van Dijk et al., 2001) . Moreover, their anti-microbial/immunomodulatory properties would be more likely to be beneficial when piglet growth may be compromised, such as in conventional on-farm nursery setting as compared to 'cleaner' off-site nursery (Coffey and Cromwell, 1995) , or in pigs weaned early v. a late weaning (Torrallardona et al., 2002) . This could be related to the health-promoting properties of SDP observed in challenged piglets. Indeed, in piglets challenged via the oral route with an ETEC strain, inclusion of porcine SDP at an 8% level in diet can reduce post-weaning diarrhoea and increase growth of piglets that are positive for F4 receptor . This effect was enhanced in piglets fed a diet containing an SDP obtained from pigs previously immunised with a vaccine against neonatal E. coli, where a concomitant decreased ETEC excretion was observed. These results confirm that protection conferred by SDP would be mainly due to specific antibodies, but also highlight the implication of less-specific components. Indeed, the decreased intestinal inflammatory response observed in SDP-fed pigs challenged with ETEC K88 may be explained by a lower colonisation or binding of E. coli to intestinal receptors as assessed by their lower serum IgA titre and histopathological score (Bosi et al., 2004) . For instance, the glycan moieties of glycoproteins would compete with natural intestinal receptors, thus reducing bacterial adhesion to the gut (Nollet et al., 1999) . Indeed, the protective effect of SDP may also be non-specific as the use of a plasma powder depleted of antibodies directed towards adhesion factors of the challenge strain of E. coli (O141:K85ab expressing the F18ac fimbriae) was efficient in protecting piglets against oedema disease (Nollet et al., 1999) . In piglets orally challenged with different strains of pathogenic E. coli
In-feed modulators of piglet immunity (van Dijk et al., 2002; Bosi et al., 2004; Yi et al., 2005; Torrallardona et al., 2007) , SDP generally prevents growth retardation and clinical signs, a phenomenon inconstantly associated with decreased circulation or excretion of pathogenic strains. This supports the theory of a direct competition of SDP with intestinal receptors for pathogenic E. coli, more than a direct anti-microbial effect (Bosi et al., 2004) . Both theories concerning mechanisms of action of SDP are likely, and may act synergistically to decrease disease susceptibility of piglets. Glycoproteins, but probably other components, may prevent attachment of pathogens to intestine in a non-specific way, which could still be reduced by specific antibodies linking to pathogens. The elimination of undesired pathogens from the gastro-intestinal tract would be facilitated.
Other animal by-products. Bovine colostrum has a critical role in postnatal health as an immune booster. Apart from the passive transfer of antibody, it provides growth-and anti-microbial factors (IGF, transforming growth factor, epidermal growth factor, lactoferrin, lysozyme, etc.), which will be beneficial to the neonate (Pakkanen and Aalto, 1997) . In piglets, bovine colostrum has been shown to enhance mucosa restoration by stimulating migration of epithelial cells along the crypt-villous axis in the intestine, and by decreasing apical cell apoptosis (Huguet et al., 2007) . Recent studies would suggest that bovine colostrum has immunomodulatory properties that are directly related to a specific region of the porcine gut-associated lymphoid tissue. Depending upon the region studied, bovine colostrum could lead to Th1 (IL-2, IFN-g and IL-12) or Th2 (IL-4 and IL-10) cytokine profiles (Boudry et al., 2007) . In ileal PP, the increase in Th2 mRNA expression (IL-4 and IL-10) was associated with an impaired Th1 profile (IFN-g), suggesting that bovine colostrum supplementation may cause a more marked Th2 immune response (Boudry et al., 2007) . In contrast, a Th1 profile was more pronounced in the jejunum. This bipolarity activities associated with bovine colostrum would be of importance in the context of exposure to a wide range of antigens (Boudry et al., 2007) . Bovine colostrum significantly decreased the total number of mononuclear cells in ileal PP, but their proliferative responses were increased (Boudry et al., 2007) . Phenotyping of the ileal PP cells showed a very significant doserelated decrease in CD21 1 cell count, concomitant with an increase in the CD3 1 cell population (involving mainly the CD4 1 subpopulation) 21 days post-weaning. Perhaps not surprisingly, the piglets mounted a strong local antibody response to the bovine colostral Igs by 21 days postweaning (Boudry et al., 2007) . The activities associated with fed bovine colostrum were mainly associated with the intestinal tract, and systemic immune responses were not altered. To our knowledge, its health benefits that could result from its orchestration of immune responses have not yet been studied and could be the subject of further investigations.
Lactoferrin is a member of the transferrin family of ironbinding glycoproteins and is ubiquitous in animal secretions (colostrum, milk, tears). It displays a wide range of physiological functions including protection against microbial infections, regulation of non-specific immune response and modulation of the inflammatory response (see Levay and Viljoen (1995) for review). Both specific and innate systemic immune responses seem dependent on lactoferrin. In pigs, it has been shown that a 15-day lactoferrin treatment increased the concentration of IL-2 in blood as well as the C4 component of complement, at levels much higher than those reached by positive controls receiving AB . Conversely, lactoferrin did not seem to have any impact on IL-1a or C3 blood concentrations. Lactoferrin enhanced the proliferation of peripheral blood and spleen lymphocytes after stimulation with phytohemagglutinin and concanavalin A (for spleen lymphocytes only). Serum concentrations of IgG, IgA and IgM were also increased in lactoferrin-supplemented piglets. To our knowledge, its impact on local intestinal immunity as well as its potential to enhance specific immune responses has not yet been investigated in pigs. The use of lactoferrin is promising, as it seems efficient in preventing diarrhoea in piglets Wang et al., 2007) .
Concluding remarks
Literature dealing with natural alternatives to in-feed AB and their impact on pig immunity is still scarce. In our opinion, two main reasons are responsible for this lack of knowledge. First, the total ban of in-feed AB is recent and published works on that topic may arise in the following years. Secondly, in-feed alternatives that can act directly on immunity, and not through the control of the microflora, have only recently gained interest. Indeed, the main mechanism proposed for the action of AB as growthenhancers was only linked to their ability to control flora. It was suggested that AB improve the efficiency of animal growth via the inhibition of intestinal microflora, leading to a reduction in the maintenance costs of the gastro-intestinal system including immune responses (Gaskins et al., 2002) . However, new data are emerging and suggest that AB may directly interact with host cells (mainly inflammatory ones), and decrease their production and excretion of catabolic mediators (Niewold, 2007) . Niewold (2007) argues that the changes in microflora would be more likely the consequence of the altered condition of the intestinal wall and that this may explain the highly reproducible effects of AB, as opposed to the inconstant results obtained with alternatives aiming at controlling the microflora. However, data obtained with different classes of alternative substances able to directly interact with natural defences of the host are not so conclusive.
As highlighted in this review, substances whose immunomodulatory properties often issue from in vitro experiments are not so potent when tested in vivo as feed additives. The heterogeneity of experiments aiming at studying the effects of feed additives on pig immunity can partly explain the discrepancies on their efficacy: variable composition of In-feed modulators of piglet immunity additives, different time for supplementation, diversity of experimental designs or measured parameters, etc. Indeed, from the feed processing to the intestinal absorption, the different compounds will be submitted to a myriad of events that can reduce their activity before they reach the cells of the gut-associated immune system (feed storage, interactions with other nutrients, digestive processes, absorption kinetics, etc.). Moreover, the level of the feed additive in the final diet often remains unknown, and in some cases, the composition of the additive itself is not revealed. This is particularly true for yeast extracts that are mainly commercial products, but also for plant extracts whose active principle(s) content is highly dependent on environmental growth conditions, harvesting time and state of maturity or storage management (Wenk, 2003) . Independent of these basic information that should be mentioned in every scientific article, some experimental designs do not seem to be fully adapted to the study of the immunomodulatory potential of in-feed additives. Indeed, this review highlights that effects of in-feed supplements on systemic immunity are quite well documented, whereas local intestinal immune responses have only received little attention. It can be understood from both a practical and an ethical point of view as the study of systemic immunity via the blood does not require the slaughter of animals, and offers the possibility of kinetic studies. However, mucosal responses can occur independently of systemic immunity (Cunningham-Rundles and Lin, 1998; Hannant, 2002) . Thus, the study of systemic immune responses may not reflect immune functions and dysfunctions occurring in the gut.
In spite of all these experimental design considerations, in the context of testing immunomodulatory compounds, one main problem is to define what 'desired' immune functions should be targeted. If there is evidence that immunosuppressive effects are expected to suppress potentially damaging reactions (chronic inflammation for instance), promotion of the active immunity is conversely required for development and education of the immune system for both short-term and long-term health (Kelly and Coutts, 2000) . This is particularly true for mucosal surfaces where a homeostatic balance has to be reached to both tolerate antigens from commensal bacteria or feed, and eliminate invading pathogens (Sansonetti, 2004) . The definition of a 'desired' immune function is thus highly complex, and in the context of animal productions, it could be defined as the one that offers both the best growth and the best health status to animals. This requires, however, that piglets are not kept under very clean conditions but are exposed to immune/infectious challenges to assess the impact of in-feed immunomodulators simultaneously on immunity and on performances and health.
In conclusion, the effects of in-feed additives on the development of immune responses in gut-associated lymphoid tissues should be more largely documented in the future, as their effects are mainly expected in this compartment. Concomitantly, pharmacokinetic studies are necessary to know the fate of these compounds in the organism, in order to precise their site of action and biological effects. Finally, relationships between immunomodulations induced by in-feed supplements and health status of animals have to be clearly stated, as the final aim of using such compounds in animal nutrition is to promote piglet performance and health.
